Viewing Study NCT04792593


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2025-12-25 @ 11:27 PM
Study NCT ID: NCT04792593
Status: UNKNOWN
Last Update Posted: 2021-03-11
First Post: 2021-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Senl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Sponsor: Hebei Senlang Biotechnology Inc., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module